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Abstract
Objective: To evaluate the effects of visual cues combined with treadmill training on gait performance in 
patients with Parkinson’s disease and to compare the strategy with pure treadmill training.
Design: Pilot, exploratory, non-blinded, randomized controlled trial.
Setting: University Hospital of Munich, Germany.
Subjects: Twenty-three outpatients with Parkinson’s disease (Hoehn and Yahr stage II–IV).
Interventions: Patients received 12 training sessions within five weeks of either visual cues combined 
with treadmill training (n = 12) or pure treadmill training (n = 11).
Main measures: Outcome measures were gait speed, stride length and cadence recorded on the 
treadmill. Functional tests included the Timed Up and Go Test, the Unified Parkinson’s Disease Rating 
Scale and the Freezing of gait-questionnaire. Assessments were conducted at baseline, after the training 
period and at two months follow-up.
Results: After the training period (n = 20), gait speed and stride length had increased in both groups 
(p ⩽ 0.05). Patients receiving the combined training scored better in the Timed Up and Go Test compared 
with the patients receiving pure treadmill training (p ⩽ 0.05). At two months follow-up (n = 13), patients 
who underwent the combined training sustained better results in gait speed and stride length (p ⩽ 0.05) 
and sustained the improvement in the Timed Up and Go Test (p ⩽ 0.05).
Conclusions: This pilot study suggests that visual cues combined with treadmill training have more 
beneficial effects on gait than pure treadmill training in patients with a moderate stage of Parkinson’s 
disease. A large-scale study with longer follow-up is required.
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Introduction
Gait disturbances are among the most disabling 
motor symptoms of Parkinson’s disease, leading to 
a substantial decline in mobility and independence, 
high rates of falls and related injuries, and a reduc-
tion in quality of life.1–4 Although pharmacological 
interventions are an essential part of therapy and 
surgical treatment has become a successful option, 
patients suffer from increasing mobility impair-
ments as the disease progresses,5 indicating a need 
for alternative gait rehabilitation approaches.
Previous work has shown that cueing techniques 
can improve gait performance in patients with 
Parkinson’s disease.5–9 Visual cues provided as 
markers on the walking surface, for example, seem 
to have a normalizing effect on the spatiotemporal 
gait parameters, specifically stride length.6
In a broader sense of the cueing concept, tread-
mill training has also proven to be effective in the 
treatment of Parkinsonian gait disorders.10–14 
Frenkel-Toledo and colleagues suggest that the 
rotation of the treadmill belt operates as an external 
cue to generate a more rhythmic gait pattern.10
Utilizing the evidence supporting visual cueing 
and treadmill training, our research group devel-
oped an intervention strategy combining treadmill 
walking and visual cues. A case study showed that 
this method helped to substantially improve the 
walking ability of a patient with a severe stage of 
Parkinson’s disease.15
The aim of the present study is to evaluate the 
effect of visual cueing in combination with tread-
mill training on walking performance, comparing 
this to pure treadmill training in a group of patients 
with a moderate to severe stage of the disease. We 
hypothesized that receiving visual cues during 
treadmill training is more successful in improving 
gait than receiving pure treadmill training.
Method
The study was performed at the Department of 
Orthopedic Surgery, Physical Medicine and 
Rehabilitation, University Hospital of Munich, 
Germany. Patients were recruited from medical 
records in our hospital and from local Parkinson 
associations to be assessed for eligibility. Inclusion 
criteria were: a diagnosis of idiopathic Parkinson’s 
disease; disease severity of II to IV on the Hoehn 
and Yahr Scale;16 ability to stand independently 
and to walk on a treadmill (with body weight sup-
port, if required); sufficient visual capacity to see 
the cues. Exclusion criteria were: any other neuro-
logic or orthopedic disorder affecting gait and pos-
tural stability; change in medication for the 
treatment of Parkinson’s disease during the study 
period; cognitive impairment indicated by less than 
24 points in the Mini-Mental State Examination 
(MMSE);17 severe cardiovascular disorders; ves-
tibular dysfunctions.
The study was approved by the local Ethics 
committee and all patients were asked to provide 
written informed consent before participation.
Participants were allocated into two treatment 
groups by an independent person. Blocked rand-
omization was used to ensure balanced group sizes. 
The randomization was conducted using numbered 
envelopes containing ten lots. Each of the enve-
lopes was filled with five lots specifying “control” 
and another five specifying “training”. Three enve-
lopes were used. Patients could not be blinded to 
group allocation.
All patients were asked to regularly take their 
Parkinson medication. Testing and training proce-
dures were individually planned and consecutively 
conducted at the same time of day during the “on”-
phase of their medication cycle.
Training procedure
Patients in both treatment groups completed 12 
training sessions within five weeks (2–3 sessions 
each week) and exercised on a motorized medical 
treadmill (h/p/cosmos sports and medical GmbH, 
Nussdorf-Traunstein, Germany). The treadmill was 
equipped by a pressure-sensitive platform (zebris 
medical GmbH, Isny, Germany) under the rotating 
belt. This enabled the recording of the patient’s foot 
pressure profile, his/her step length and cadence, as 
well as other gait parameters.
An instructed physiotherapist supervised the 
training sessions. During the first session, all 
patients trained for 20 minutes using their preferred 
walking speed (determined during the initial 
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measurements at baseline, described below). 
Throughout the following sessions, training dura-
tion and treadmill speed were adapted to the 
patient’s progress in activity level. All patients had 
reached a training duration of at least 35 to at most 
45 minutes at the final session.
In Group 1, the training consisted of treadmill 
walking (with up to 20% of body weight support, if 
required) in combination with visual cues that were 
projected onto the treadmill belt. We used the cus-
tom-tailored RehaWalk® software (zebris medical 
GmbH, Isny, Germany) for the projection of the 
cues. Before the training period started, the pres-
sure profiles, i.e. the left and the right footprint of 
each patient, were recorded. The shapes of the sub-
ject’s footprints were used as individual cues 
(Figure 1, available online). A projector (NEC 
Display Solutions Europe GmbH, Munich, 
Germany) at the front side of the treadmill dis-
played these in synchrony with the treadmill speed. 
Patients were instructed to step as precisely as pos-
sible onto the footprints during treadmill walking. 
The initial step length of each patient was taken to 
adjust the sagittal distance of the projected foot-
prints. For the first training session, the sagittal dis-
tance of the projected cues was enlarged by 10% in 
comparison to the measured step length in order to 
facilitate improvement. For the following training 
sessions, the sagittal distance was continuously 
increased according to the individual progress in 
gait performance.
In Group 2, the training consisted of pure tread-
mill training (with up to 20% of body weight sup-
port, if required). No instructions on gait 
performance were given.
Testing procedure
All measurements were conducted at baseline (pre), 
after the training period (post) and after two months 
(follow-up) by two trained examiners who were not 
blinded to group allocation. The cognitive status 
was only assessed at baseline using the MMSE.
Gait speed, stride length and cadence were 
recorded over a period of 30 seconds during tread-
mill walking using the zebris gait analysis system. 
Severely affected patients (Hoehn and Yahr stage 
IV) were bodyweight supported up to 20%. All 
other patients were secured during treadmill walk-
ing by the same system, but without body weight 
support. Before the initial measurement, patients 
were familiarized with treadmill walking for six 
minutes. During this adaption phase, the patients 
were instructed to identify their subjective pre-
ferred and maximum walking speed. Maximum 
walking speed was taken for the gait analysis.
Functional walking performance was assessed 
using the Timed Up and Go Test.18 If applicable, 
patients used their walking device for completing 
the test. To evaluate freezing of gait, the Freezing 
of Gait-Questionnaire was administered.19 
Furthermore, the Motor section of the Unified 
Parkinson’s Disease Rating Scale (UPDRS III) was 
used to evaluate overall motor abilities.20
Data analysis
Within a previous case study, one severely affected 
patient with Parkinson’s disease achieved an 
improvement of 12.5 cm (left) and 18 cm (right) in 
step length after treadmill training with visual 
cues.15 Therefore, a mean stride length difference 
of 15 cm in Group 1 and 5 cm in Group 2 with a 
standard deviation of 8 cm was assumed for a- 
priori sample size calculation. The required sample 
size was 11 participants in each group (power = 
80%, α-level = 5%).
Demographic and clinical features as well as 
gait characteristics were descriptively summarized. 
We used an exploratory testing procedure (without 
α-adjustment) to detect which mobility parameters 
respond to the combined treatment strategy and to 
generate hypotheses for further investigation. 
Owing to the non-normally distributed continuous 
data, non-parametric tests were used. The Mann–
Whitney U-test was performed to detect between-
group differences and the Wilcoxon signed ranks 
analysis was carried out to compare within-group 
effects. The α-level was set at P < 0.05.
Data were analyzed using the SPSS statistical 
software package 20 (IL, Chicago).
Results
A total of 23 patients were allocated to the two 
training groups, 20 patients completed the training 
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and 13 patients were assessed two months after the 
training period (Figure 2). Demographic and clini-
cal characteristics of the patients are presented in 
Table 1. At baseline, there was no difference 
between the two groups in any of the demographic, 
clinical or outcome parameters.
Table 2 gives a summary of the outcome meas-
ures at each time of assessment. Change scores 
over time and differences between the two groups 
are presented in Table 3.
Within both groups, gait speed and stride length 
improved after the training period (Group 1: 
p = 0.000 and p = 0.001, respectively; Group 2: 
p = 0.001 and p = 0.002, respectively), whereas the 
time to complete the Timed Up and Go Test and the 
score of the UPDRS III decreased only in Group 1 
(p = 0.006 and p = 0.019, respectively). Cadence 
did not change within both groups (p = 0.665 and 
p = 0.650, respectively), indicating that the 
enhanced gait speed was achieved by increasing 
the stride length rather than the cadence. Upon fol-
low-up after two months, both Group 1 and Group 
2 showed lower values in gait speed (p = 0.046 and 
p = 0.018, respectively) and stride length (p = 0.028 
Figure 2. Flow diagram.
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and p = 0.008, respectively) but the decrease was 
larger in Group 2 (Table 3). The time to complete 
the Timed Up and Go Test changed in neither 
Group 1 (p = 0.912) nor Group 2 (p = 0.237).
The increase of stride length in Group 1 was 
positively correlated with the score of the freezing 
of gait questionnaire (rSpearman = 0.87; p = 0.001), 
suggesting that patients with higher freezing scores 
Table 1. Demographic and clinical characteristics at baseline.
Group 1a Group 2b
 n = 10 n = 10
Age, years Mean (SD) 71.2 (10.9) 68.9 (6.8)
Female gender n (%) 8 (80.0) 6 (60.0)
Disease duration, years Mean (SD) 10.4 (5.2) 9.1 (3.1)
Hoehn and Yahr stage Mean (SD) 2.8 (0.9) 2.7 (0.7)
MMSE Mean (SD) 28.6 (1.6) 28.4 (1.6)
UPDRS: Unified Parkinson’s Disease Rating Scale (motor section); FoG-Q: Freezing of Gait-Questionnaire; MMSE: Mini-Mental 
State Examination.
aPatients receiving treadmill training in combination with visual cues.
bPatients receiving pure treadmill training.
Table 2. Outcome measures at baseline, after the training period and at two months follow-up.
Group 1a Group 2b
 n Mean (SD) Median (range) n Mean (SD) Median (range)
Gait speed, km/h T1 10 1.7 (0.8) 1.7 (1.3, 2.0) 10 2.4 (0.7) 2.6 (1.7, 2.8)
T2 10 2.6 (0.7) 2.8 (2.2, 3.1 ) 10 3.5 (0.9) 3.2 (2.8, 4.5)
T3 6 2.6 (0.5) 2.6 (2.2, 2.9) 7 2.5 (1.1) 2.1 (1.5, 3.9)
Stride length, cm T1 10 61.1 (29.6) 65.1 (44.6, 86.3) 10 75.1 (18.2) 76.8 (64.6, 86.9)
T2 10 90.4 (21.7) 97.0 (83.2, 101.8) 10 104.5 (21.7) 100.1 (92.5, 120.5)
T3 6 78.4 (23.4) 89.7 (58.8, 94.9) 7 82.2 (25.2) 73.5 (60.5, 106.9)
Cadence, steps/min T1 10 99.9 (28.1) 98.6 (72.9, 114.5) 10 107.4 (21.8) 108.7 (97.8, 121.5)
T2 10 95.4 (10.9) 99.7 (88.0, 102.4) 10 110.0 (13.2) 112.4 (102.9, 119.0)
T3 6 95.6 (8.4) 99.0 (86.1, 102.6) 7 99.7 (23.1) 102.3 (75.2, 119.4)
Timed Up and Go Test, s T1 10 14.4 (6.8) 12.5 (7.5, 18.1) 10 10.9 (4.7) 10.2 (7.1, 13.9)
T2 10 11.8 (5.5) 9.9 (6.9, 13.9) 10 10.8 (4.0) 10.4 (7.1, 14.0)
T3 6 10.9 (4.4) 10.7 (6.4, 15.8) 7 10.4 (5.0) 7.1 (6.8, 14.5)
UPDRS III T1 10 28.9 (13.8) 26.0 (14.8, 43.3) 10 25.3 (15.1) 25.5 (9.8, 36.8)
T2 10 23.8 (13.5) 24.5 (12.5, 33.8) 10 23.4 (10.1) 26.0 (12.8, 31.5)
T3 6 21.8 (13.4) 18.5 (10.5, 38.0) 7 28.2 (13.7) 23.5 (19.5, 35.5)
FOG-Q T1 10 9.6 (5.7) 10.5 (5.5, 15.3) 10 10.5 (6.2) 11.5 (5.0, 16.3)
T2 10 10.0 (6.9) 10.0 (3.8, 15.5) 10 9.8 (6.5) 10.5 (3.0, 16.0)
T3 6 3.2 (4.1) 2.5 (0.0, 5.0) 7 4.2 (4.5) 3.0 (2.3, 5.5)
T1: baseline assessment; T2: assessment after the training period (six weeks after baseline); T3: assessment at two months 
follow-up (14 weeks after baseline); UPDRS: Unified Parkinson’s Disease Rating Scale (motor section); FoG-Q: Freezing of Gait-
Questionnaire.
aPatients receiving treadmill training in combination with visual cues.
bPatients receiving pure treadmill training.
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showed a greater benefit from the combined train-
ing strategy than patients with lower freezing 
scores. No such correlation was found for Group 2 
(rSpearman = 0.23; p = 0.521).
Discussion
The findings of this study support the hypothesis that 
visual cueing with treadmill training has more bene-
ficial impact on gait performance than pure treadmill 
training. First, only the combined training strategy 
helped to improve functional walking performance, 
assessed by the Timed Up and Go Test. Second, gait 
speed and stride length increased in both training 
groups, but patients who received the additional cues 
sustained better results over two months.
In addition, visual cues during treadmill training 
seemed to be particularly successful in enhancing 
stride length of patients suffering from freezing of 
gait.
Some major limitations of this study need to be 
considered. Although not statistically significant, 
Group 2 scored better in several baseline assess-
ments, particularly the Timed Up and Go Test. This 
means that there was less potential for improvement 
and a possible ceiling effect of performance in 
Group 2. The following aspects might have caused 
adverse effects on the validity of the study. Like in 
most pilot clinical trials, the sample size was small 
and cannot be representative for all patients with 
Parkinson’s disease. Furthermore, 35% of the 
patients were lost to follow-up, reducing the number 
of patients to six and seven in the two groups. 
Therefore, results may be subject to type II errors as 
well as attrition bias and need to be interpreted with 
caution. Blinding of participants and the physiother-
apist who supervised the training sessions was not 
possible owing to the nature of the interventions. 
The fact that participants were aware of the group 
allocation may have caused a decline in motivation, 
and thus, a potential lack of treatment success, espe-
cially among the patients receiving only treadmill 
training without the additional cues. To improve the 
participant’s compliance, they were offered to 
receive the respective other treatment after cessation 
of the study. Experimenter bias could have been 
introduced by the physiotherapist during the training 
sessions. To counter this, the therapist was instructed 
Table 3. Change in outcome measures after the training period and at two months follow-up.
Group 1a Group 2b p-value
 n Change 
Mean (SD)





T2–T1 10 0.9 (0.4) 1.0 (0.5, 1.2) 10 1.1 (0.7) 1.1 (0.5, 1.7) 0.579
T3–T2 6 −0.4 (0.3) −0.3 (−0.7, −0.2) 7 −0.9 (0.5) −0.9 (−1.1, −0.5) 0.035c
Stride length, 
cm
T2–T1 10 29.3 (19.7) 23.4 (15.6, 39.8) 10 29.3 (21.1) 23.7 (10.3, 47.5) 0.912
T3–T2 6 −7.3 (10.4) −7.8 (−17.5, 3.2) 7 −23.6 (15.3) −24.4 (−27.8, −12.5) 0.038c
Cadence, 
steps/min
T2–T1 10 −4.5 (31.8) 3.2 (−12.1, 11.9) 10 2.7 (18.1) 4.8 (−7.9, 13.1) 0.684
T3–T2 6 −3.4 (7.2) −2.5 (−9.1, 1.9) 7 −6.1 (15.3) −7.3 (−16.3, −1.8) 0.366
Timed Up and 
Go Test, s
T2–T1 10 −3.6 (2.3) −2.3 (−4.2, −0.6) 10 −0.2 (1.6) −0.1 (−1.5, 1.5) 0.023c
T3–T2 6 −0.1 (1.6) −0.2 (−0.9, 1.3) 7 −0.5 (2.6) −0.7 (−1.9, −0.2) 0.445
UPDRS III T2–T1 10 −5.1 (5.0) −6.0 (−9.5, −1.0) 10 −1.9 (8.7) −1.0 (−7.0, 4.0) 0.218
T3–T2 6 3.3 (5.6) 3.0 (−0.3, 6.2) 6 4.8 (10.5) 2.5 (−1.8, 11.3) 0.937
FOG-Q T2–T1 10 0.4 (3.3) 0.0 (−1.3, 2.5) 10 −0.7 (1.8) −1.5 (−2.0, 0.5) 0.218
T3–T2 6 −4.0 (3.5) −4.5 (−6.8, 0.0) 6 −8.3 (5.8) −10.0 (−13.3, −2.3) 0.240
T1: baseline assessment; T2: assessment after the training period (six weeks after baseline); T3: assessment at two months 
follow-up (14 weeks after baseline); UPDRS: Unified Parkinson’s Disease Rating Scale (motor section); FoG-Q: Freezing of Gait-
Questionnaire.
aPatients receiving treadmill training in combination with visual cues.
bPatients receiving pure treadmill training.
cSignificant difference between the two groups (p < 0.05)
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to avoid any kind of encouragement. As the asses-
sors were not blinded, observer bias may have 
affected the results. This weakness could have par-
ticularly influenced the walking speed on the tread-
mill. However, patients were instructed to adjust 
their preferred and maximum speeds individually 
while only being supervised by the assessor, and fur-
thermore, mobility measures were objective. It is 
worthwhile to initiate a multi-center assessor-
blinded randomized controlled trial to evaluate the 
efficacy of visual cues during treadmill training 
within a large sample of patients with Parkinson’s 
disease. The Timed Up and Go Test would be an 
appropriate primary outcome measure.
It is well known that patients with Parkinson’s 
disease compensate for short stride length by 
increasing the cadence.1 In this study, both training 
groups showed improvement in gait speed and 
stride length while cadence did not change. This 
may indicate that patients who train on a treadmill 
learn how to modulate gait speed by regulating 
stride length rather than cadence. Previous research 
already found that treadmill walking facilitates 
positive effects on the spatiotemporal gait parame-
ters, probably owing to the repetitive and pace-
dictating stimulation of the walking task.10,11,12
Frazzitta et al. studied the efficacy of treadmill 
training with visual cues presented on a screen 
compared with conventional therapy with cues in 
Parkinson patients with freezing.21 Similar to our 
results, they found that the combination was more 
effective to improve gait performance. Most of all, 
patients scored better in the 6-minute walking test. 
Luessi and colleagues investigated the interaction 
of treadmill walking and visual cues attached to the 
belt on the spatiotemporal gait parameters.22 Under 
the cued condition, stride length increased while 
cadence decreased. Furthermore, they found out 
that the effect of the visual cues was related to gait 
speed, meaning that the positive influence on stride 
length and gait speed was greater at slow velocities 
(around 1–2 km/h). Together with our data, this 
study suggests that the combined intervention is 
most efficient at slow training speeds.
Better results in the Timed Up and Go Test 
could only be achieved in patients who underwent 
the combined training, and these patients seemed 
to sustain the gain in functional gait performance 
over two months. This finding proposes that the 
visual stimulation helps to transfer and integrate 
the training effects into walking on the natural 
ground. The patients in Group 1 were interviewed 
after the training period to find a possible explana-
tion. The severely affected patients reported to 
mentally visualize their footprints on the ground in 
front of them whenever they experience difficulties 
generating continuous walking, whereas the mildly 
affected patients reported improvements without 
using any specific strategy. These observations 
may demonstrate that severely affected patients are 
dependent on visual information (even if it is imag-
inary) to focus their attention on walking, while 
less affected patients still have the ability to 
improve walking performance by motor learning. 
This hypothesis is supported by the findings 
of Morris and colleagues.23 They recommend 
compensatory techniques, particularly visual and 
auditory cues, for the moderate to severe stage and 
motor skill learning strategies, namely repetitive 
task-complex training, for the early stage of the 
Parkinson’s disease.23
Freezing of gait was positively correlated with 
the increase in stride length after receiving visual 
cues in combination with treadmill training. 
Freezing is the clinical symptom of impaired auto-
matic motor control caused by a functional mis-
communication of the locomotor network, 
manifested as reduced connectivity between the 
supplementary motor area and the subthalamic 
nucleus, and greater connectivity between the sup-
plementary motor area and the mesencephalic and 
cerebellar motor regions.24 A recent review pre-
sents four theoretical models that might explain the 
episodic emergence of freezing.25 Two of them, the 
threshold and the interference model,25,26,27 best 
describe the superior effect mechanism of the com-
bined training in freezers. The threshold model 
assumes that freezing is induced by the accumula-
tion of motor impairments, such as reduced step 
scaling, coordination and symmetry, and decreased 
gait rhythmicity, resulting in a breakdown of loco-
motion.25,26 Treadmill walking could help to gener-
ate a more rhythmic and regular gait pattern, 
thereby preventing the threshold from reaching the 
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level of freezing. The interference model proposes 
that freezing occurs owing to the incapacity to pro-
cess concurrent cognitive, limbic and motor input, 
which again leads to a breakdown of locomo-
tion.25,27 Visual cues may help to correct the inter-
ference between neural circuits by channeling 
information through intact pathways.27,28 As the 
pharmacological treatment of freezing remains dif-
ficult,28 the combination of treadmill training and 
visual cueing could guide the way to designing 
successful therapy approaches for these patients.
Clinical messages
•• Adding visual cues during treadmill 
training improves the gait performance in 
patients with a moderate to severe stage 
of Parkinson’s disease, and particularly 
in patients with freezing.
•• The combined training helps to translate 
the gait improvements from treadmill 
walking into normal walking on the natu-
ral surface.
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